SCHEMBL3674588

SCHEMBL3674588

COc1cc(C(C)(C)C)c(OC)c(C(C)(C)C2=CC([Si](C)(C)C(C)(C)C)C=C2)c1

nearest known ligand 0.36

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
PTGS2 P35354 3/20 0.33
PTGS1 P23219 1/20 0.33
TNFRSF1A P19438 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3678872 0.90 PTGS2 (0.33) PTGS2PTGS1
SCHEMBL3687013 0.90 CA1 (0.38) CA1CA2PTGS2PTGS1TNFRSF1A
SCHEMBL3677352 0.89 PTGS2 (0.32) PTGS2PTGS1
SCHEMBL3672515 0.85
SCHEMBL3681444 0.80
SCHEMBL3683203 0.79 PTGS2 (0.34) CA2PTGS2PTGS1
SCHEMBL3677625 0.78 PTGS2 (0.33) PTGS2PTGS1
SCHEMBL3681037 0.78 CA1 (0.35) CA1CA2PTGS2PTGS1TNFRSF1A
SCHEMBL3676695 0.78
SCHEMBL5086563 0.76 CA1 (0.31) CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1785429-B1 PROCESS FOR PRODUCING METALLOCENE COMPOUND SUMITOMO CHEMICAL CO (JP) 2012-10-03 EP disclosed
US-7652159-B2 Process for producing metallocene compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-01-26 US disclosed
US-20080319213-A1 Process For Producing Metallocene Compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-12-25 US disclosed
EP-1785429-A1 PROCESS FOR PRODUCING METALLOCENE COMPOUND Sumitomo Chemical Company, Limited (JP) 2007-05-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080319213-A1 Process For Producing Metallocene Compound H1-10, CNOT9, H1-4 CA1 759/4885CA2 2089/4885PTGS2 4199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.